GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Adicon Holdings Ltd (OTCPK:ADCNF) » Definitions » Notes Receivable

Adicon Holdings (Adicon Holdings) Notes Receivable : $0.0 Mil (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Adicon Holdings Notes Receivable?

Adicon Holdings's Notes Receivable for the quarter that ended in Dec. 2023 was $0.0 Mil.


Adicon Holdings Notes Receivable Historical Data

The historical data trend for Adicon Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adicon Holdings Notes Receivable Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Notes Receivable
- - - -

Adicon Holdings Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial - - - - -

Adicon Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Adicon Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Adicon Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Adicon Holdings (Adicon Holdings) Business Description

Comparable Companies
Traded in Other Exchanges
Address
No. 208, Zhenzhong Road, West Lake, Zhejiang, Hangzhou, CHN
Adicon Holdings Ltd is one of the top three independent clinical laboratory or ICL, service providers in China. The company offers comprehensive and best-in-class testing services primarily to hospitals and health check centers through an integrated network of 33 self-operated laboratories across China. The high quality of its services is backed by its strong performance in terms of international accreditation and comprehensive testing menu. Its testing portfolio consists of over 4,000 medical diagnostic tests, including over 1,700 routine tests and over 2,300 esoteric tests. It has three major service platforms. Among them, the inspection service platform consists of clinical, pathology, reproductive genetic, genetic, and mass spectrometry laboratories.

Adicon Holdings (Adicon Holdings) Headlines

No Headlines